Short description
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices.
Description
Sensimed designs, develops, and commercializes integrated micro-systems for medical devices. The company’s product portfolio includes SENSIMED Triggerfish, a product that offers an automated recoding of continuous ocular dimensional change over 24 hours.
Sensimed is now focused on expanding the knowledge of how this individual data can best be used in the clinical setting to deliver customized treatment. The 24 hour profiles are being centralized on a registry together with patient and treatment information. The data is being analyzed and modeled on an ongoing basis in an attempt to identifying pathological patterns that can be used to differentiate indication, personalize treatment and assess efficacy following treatment.
Sensimed was founded by Matteo Leonardi and Sacha Cerboni in August 2003 and is based in Lausanne, Switzerland.
Last funding
No Way
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
Lausanne, Vaud, Switzerland, Europe
Founded on
January 1, 2003
Exited on
December 12, 2019
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noway Youcantaccess, Blurry Noaccess, Noaccess, Noaccess, Cannot Access, Absolutely Noaccess, Noway Youcantaccess, Blurry Noaccess
Sign in for full access
Founders
Matteo Leonardi, Sacha Cerboni